Screener
Monte Rosa Therapeutics, Inc. GLUE Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Monte Rosa Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:09 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336711
| (in thousands, except share and per share amounts) | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net | 29,932 | 25,986 |
| Operating lease right-of-use assets | 24,056 | 24,386 |
| Restricted cash | 4,939 | 4,954 |
| Other long-term assets | 828 | 148 |
| Total assets | $691,161 | $448,659 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $7,152 | $3,550 |
Item 1. Financial Statements
FAQ
- What is Monte Rosa Therapeutics, Inc.'s other non-current assets?
- Monte Rosa Therapeutics, Inc. (GLUE) reported other non-current assets of $828K in Q2 2026.
- How has Monte Rosa Therapeutics, Inc.'s other non-current assets changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s other non-current assets increased by 86.1% year-over-year, from $445K to $828K.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Monte Rosa Therapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude